Changmao Biochemical Engineering Company Limited (0954.HK)
HKD 0.41
(-1.22%)
HKD 0.41
(-1.22%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 25.8 Million CNY | -85.73% |
| 2022 | 180.83 Million CNY | 367.51% |
| 2021 | 38.68 Million CNY | -62.46% |
| 2020 | 103.04 Million CNY | -23.76% |
| 2019 | 135.15 Million CNY | 4.18% |
| 2018 | 129.72 Million CNY | 72.98% |
| 2017 | 74.99 Million CNY | -28.94% |
| 2016 | 105.53 Million CNY | -8.1% |
| 2015 | 114.83 Million CNY | 3.14% |
| 2014 | 111.32 Million CNY | -34.13% |
| 2013 | 169 Million CNY | 32.6% |
| 2012 | 127.45 Million CNY | 11.62% |
| 2011 | 114.18 Million CNY | -16.87% |
| 2010 | 137.36 Million CNY | 53.75% |
| 2009 | 89.34 Million CNY | -0.74% |
| 2008 | 90 Million CNY | 15.59% |
| 2007 | 77.86 Million CNY | -25.28% |
| 2006 | 104.21 Million CNY | 36.38% |
| 2005 | 76.41 Million CNY | -2.3% |
| 2004 | 78.2 Million CNY | 1.6% |
| 2003 | 76.97 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 7.99 Million CNY | 0.0% |
| 2024 Q1 | 7.99 Million CNY | -30.15% |
| 2023 Q4 | 11.44 Million CNY | 0.0% |
| 2023 FY | 25.8 Million CNY | -85.73% |
| 2023 Q1 | 20.73 Million CNY | -53.83% |
| 2023 Q2 | 20.73 Million CNY | 0.0% |
| 2023 Q3 | 11.44 Million CNY | -44.81% |
| 2022 FY | 180.83 Million CNY | 367.51% |
| 2022 Q3 | 44.9 Million CNY | -1.32% |
| 2022 Q4 | 44.9 Million CNY | 0.0% |
| 2022 Q1 | 45.5 Million CNY | 243.75% |
| 2022 Q2 | 45.5 Million CNY | 0.0% |
| 2021 Q4 | 13.23 Million CNY | 0.0% |
| 2021 Q1 | 14.87 Million CNY | -34.57% |
| 2021 Q2 | 14.87 Million CNY | 0.0% |
| 2021 Q3 | 13.23 Million CNY | -11.02% |
| 2021 FY | 38.68 Million CNY | -62.46% |
| 2020 Q3 | 22.73 Million CNY | -9.0% |
| 2020 Q4 | 22.73 Million CNY | 0.0% |
| 2020 Q1 | 24.98 Million CNY | 24.0% |
| 2020 FY | 103.04 Million CNY | -23.76% |
| 2020 Q2 | 24.98 Million CNY | 0.0% |
| 2019 Q4 | 20.15 Million CNY | 0.0% |
| 2019 Q2 | 47.42 Million CNY | 0.0% |
| 2019 Q1 | 47.42 Million CNY | 35.8% |
| 2019 Q3 | 20.15 Million CNY | -57.51% |
| 2019 FY | 135.15 Million CNY | 4.18% |
| 2018 Q2 | 29.93 Million CNY | 0.0% |
| 2018 FY | 129.72 Million CNY | 72.98% |
| 2018 Q4 | 34.92 Million CNY | 0.0% |
| 2018 Q3 | 34.92 Million CNY | 16.66% |
| 2018 Q1 | 29.93 Million CNY | 55.91% |
| 2017 Q2 | 18.29 Million CNY | 0.0% |
| 2017 FY | 74.99 Million CNY | -28.94% |
| 2017 Q4 | 19.2 Million CNY | 0.0% |
| 2017 Q3 | 19.2 Million CNY | 4.95% |
| 2017 Q1 | 18.29 Million CNY | -15.46% |
| 2016 Q4 | 21.64 Million CNY | 0.0% |
| 2016 Q2 | 31.12 Million CNY | 0.0% |
| 2016 Q3 | 21.64 Million CNY | -30.47% |
| 2016 Q1 | 31.12 Million CNY | -2.14% |
| 2016 FY | 105.53 Million CNY | -8.1% |
| 2015 FY | 114.83 Million CNY | 3.14% |
| 2015 Q3 | 31.8 Million CNY | 24.2% |
| 2015 Q4 | 31.8 Million CNY | 0.0% |
| 2015 Q1 | 25.6 Million CNY | 7.24% |
| 2015 Q2 | 25.6 Million CNY | 0.0% |
| 2014 Q2 | 31.78 Million CNY | 0.0% |
| 2014 Q1 | 31.78 Million CNY | -29.73% |
| 2014 FY | 111.32 Million CNY | -34.13% |
| 2014 Q4 | 23.87 Million CNY | 0.0% |
| 2014 Q3 | 23.87 Million CNY | -24.87% |
| 2013 Q2 | 42.27 Million CNY | 16.57% |
| 2013 FY | 169 Million CNY | 32.6% |
| 2013 Q4 | 45.23 Million CNY | 0.0% |
| 2013 Q3 | 45.23 Million CNY | 6.99% |
| 2013 Q1 | 36.26 Million CNY | 14.57% |
| 2012 Q3 | 38.15 Million CNY | 18.88% |
| 2012 FY | 127.45 Million CNY | 11.62% |
| 2012 Q4 | 31.65 Million CNY | -17.04% |
| 2012 Q2 | 32.09 Million CNY | 25.67% |
| 2012 Q1 | 25.54 Million CNY | -2.15% |
| 2011 FY | 114.18 Million CNY | -16.87% |
| 2011 Q3 | 27.99 Million CNY | -4.06% |
| 2011 Q1 | 30.91 Million CNY | -37.18% |
| 2011 Q2 | 29.18 Million CNY | -5.6% |
| 2011 Q4 | 26.1 Million CNY | -6.76% |
| 2010 Q3 | 33.41 Million CNY | 6.31% |
| 2010 Q4 | 49.21 Million CNY | 47.26% |
| 2010 FY | 137.36 Million CNY | 53.75% |
| 2010 Q2 | 31.43 Million CNY | 0.0% |
| 2009 FY | 89.34 Million CNY | -0.74% |
| 2009 Q2 | 24.7 Million CNY | 0.0% |
| 2008 FY | 90 Million CNY | 15.59% |
| 2007 FY | 77.86 Million CNY | -25.28% |
| 2006 FY | 104.21 Million CNY | 36.38% |
| 2005 FY | 76.41 Million CNY | -2.3% |
| 2004 FY | 78.2 Million CNY | 1.6% |
| 2003 FY | 76.97 Million CNY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Wai Chun Bio-Technology Limited | 50.41 Million HKD | 48.805% |
| Lee & Man Chemical Company Limited | 1.06 Billion HKD | 97.57% |